Related Experiment Video
Updated: Jul 16, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
Human T-lymphotropic virus 1: recent knowledge about an ancient infection
Kristien Verdonck1, Elsa González, Sonia Van Dooren
1Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru. tverdonck@itg.be
Human T-lymphotropic virus 1 (HTLV-1) causes severe diseases like adult T-cell leukaemia and myelopathy, despite most carriers being asymptomatic. Research is advancing, but effective treatments and prognostic markers for HTLV-1 infection remain limited.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- Human T-lymphotropic virus 1 (HTLV-1) is an ancient human retrovirus with significant global prevalence.
- Transmission occurs via mother-to-child, sexual contact, and blood products, with hotspots in Japan, Africa, the Caribbean, and South America.
- While most infections are asymptomatic, HTLV-1 is linked to serious neoplastic, inflammatory, and infectious diseases.
Purpose of the Study:
- To review the current understanding of HTLV-1 infection, pathogenesis, and associated diseases.
- To highlight the advancements in understanding virus-host interactions.
- To identify gaps in prognostic markers and therapeutic options for HTLV-1.
Main Methods:
- Literature review and synthesis of existing research on HTLV-1.
- Analysis of epidemiological data on HTLV-1 prevalence and transmission.
- Categorization of HTLV-1-associated diseases based on clinical manifestations.
Main Results:
- HTLV-1 infection persists globally, with specific endemic regions showing high prevalence.
- Associated diseases include adult T-cell leukaemia/lymphoma, HTLV-1-associated myelopathy/tropical spastic paraparesis, uveitis, and opportunistic infections like Strongyloides stercoralis hyperinfection.
- Significant progress has been made in understanding the complex interplay between HTLV-1 and the host immune response.
Conclusions:
- Despite improved understanding of HTLV-1 pathogenesis, effective treatments are scarce.
- There is an unmet need for reliable surrogate markers to predict prognosis in HTLV-1-infected individuals.
- Further research is crucial for developing targeted therapies and improving patient outcomes for HTLV-1-related conditions.
More Related Videos
Related Concept Videos
Retroviruses
Non-LTR Retrotransposons
Viral Recombination
Cytomegalovirus Disease
Viral Mutations
Herpes

